Reduced insulin use and diabetes complications upon introduction of SGLT-2 inhibitors and GLP1-receptor agonists in low- and middle-income countries: A microsimulation. . PLoS Med 2025;22:e1004559.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Reduced insulin use and diabetes complications upon introduction of SGLT-2 inhibitors and GLP1-receptor agonists in low- and middle-income countries: A microsimulation. PLoS Med 2025;22:e1004559.
PMID: 40245017